Thomas A. Waldmann Award

Thomas A. Waldmann Award for Excellence in Human Immunology

At the recommendation of the members of International scientific Advisory Board, the Board of Directors  established Thomas A. Waldmann Award for Excellence in Human Immunology as a tribute to Dr. Thomas A. Waldman for his many seminal contributions of to human immunology, especially his contributions to immunoglobulin catabolism, immunoglobulin gene rearrangement,  regulatory cells in common variable immunodeficiency, and discovery of IL-2 receptor alpha chain (CD25), and IL-15.

The Thomas A. Waldmann Award for Excellence in Human Immunology will be awarded to an immunologist/cell biologist who has made major contributions directly or indirectly to the understanding of primary immunodeficiency diseases.

Thomas A. Waldmann, M.D.

 


 

Yanick Crow, Ph.D.

Recipient of 2017 ThomaAWaldmann Award foExcellence in Human Immunology

Yanick Crow received his degree in Medicine from Newcastle University, UK, and MRCP in adult medicine in Glasgow.Subsequently worked in paediatrics in Stirling, and then undertook training in Clinical Genetics at Yorkhill Hospital. Inspired by Professor John Stephenson and Dr John Tolmie he became interested in neurogenetics and moved to Leeds where he undertook a PhD on the genetics of Aicardi-Goutières syndrome (AGS) with Dr Geoff Woods and Sir Alex Markham. Between 2001 and 2006 I was a full-time NHS consultant in the Yorkshire Regional Genetics Service, at which point he took up a post as Senior Lecturer in the Leeds Institute of Molecular Medicine working closely with Professor David Bonthron. In 2008 he became a Professor in Genetic Medicine at the University of Manchester.

Currently, he is a Laboratory Director, Institut Imagine, INSERM, U1163, Universite Paris Descartes, Paris, France, and Professor of Genetic Medicine, Manchester Center for Genomic Medicine, University of Manchester, UK.

His work has concentrated on the Mendelian inflammatory disorder Aicardi-Gouti̬res syndrome (AGS). Clinical and genetic studies of this severe disease have helped to define a cell-intrinsic mechanism for the initiation of autoinflammation / autoimmunity by interferon-stimulatory nucleic acids, and have further emphasized the importance of type I interferon metabolism in the pathogenesis of certain non-Mendelian disorders, particularly systemic lupus erythematosus. A combination of clinical, genetic and immunological perspectives have led his group to suggest that monogenic disorders associated with an upregulation of type I interferons represent a novel set of inborn errors of immunity due to abnormal sensing, inappropriate stimulation, or defective negative regulation of the type I interferon system Рthe so-called type I interferonopathies.

Dr. Crow is a Fellow of the Academy of Medical Sciences (UK), Member, MRC Molecular and Cellular Medicine Board, Chairman, Scientific Committee of the European Leukodystrophy Association.

 


Recipients of the Thomas A. Waldmann Award for Excellence in Human Immunology

 

2016-Luigi Notarangelo

2015- Daniel Kastner

2014 - Rochelle Hirschhorn

2013 - Rebecca Buckley

2012 - Mary Ellen Conley

2011 - Max D. Cooper